Cite

HARVARD Citation

    Araki, E. et al. (n.d.). Long‐term safety of linagliptin monotherapy in Japanese patients with type 2 diabetes. Diabetes, obesity & metabolism. 15 (4), pp. 364-371. [Online]. 
  
Back to record